[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:biliary-atresia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":62,"states":63},"Biliary Atresia",8,7,[8,16,23,30,36,42,48,54],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT02137668","Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin",[12],"Phase 1","RECRUITING","2026-08-26T02:15:11.740957Z","2026-05-05T02:43:28.176136Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07513038","Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:30.351130Z","2026-05-05T02:43:28.986012Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07250854","The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis",[27],"Early Phase 1","2026-08-26T02:19:06.150683Z","2026-05-05T02:35:31.763005Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT03273049","Mapping Disease Pathways for Biliary Atresia",[],"2026-08-26T02:16:34.792807Z","2026-05-13T02:55:06.120162Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT00345553","Biliary Atresia Study in Infants and Children",[],"2026-08-26T02:19:19.975067Z","2026-05-13T02:55:06.034882Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT00061828","A Prospective Database of Infants With Cholestasis",[],"2026-08-26T02:18:46.948970Z","2026-05-13T02:55:06.030886Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT01793168","Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.077983Z",{"nct_id":55,"title":56,"phases":57,"status":59,"updated_at":60,"content_modified":61},"NCT05426733","An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia",[58],"Phase 3","ENROLLING_BY_INVITATION","2026-08-26T02:19:04.543908Z","2026-06-16T05:54:08.031091Z",[],[64,68,71,74,77,80,83,86,89],{"state":65,"count":66,"slug":67},"California",3,"california",{"state":69,"count":66,"slug":70},"Colorado","colorado",{"state":72,"count":66,"slug":73},"Georgia","georgia",{"state":75,"count":66,"slug":76},"Indiana","indiana",{"state":78,"count":66,"slug":79},"Missouri","missouri",{"state":81,"count":66,"slug":82},"New York","new-york",{"state":84,"count":66,"slug":85},"Ohio","ohio",{"state":87,"count":66,"slug":88},"Pennsylvania","pennsylvania",{"state":90,"count":66,"slug":91},"Washington","washington"]